Company / Total Assets
ENDONOVO THERAPEUTICS, INC. Total Assets History
FY2011-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3M
FY2022
5-year range
$1.3M / $4.2M
FY2018-FY2022
Trend
-36.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $4M in FY2018 to $1M in FY2022.
Based on SEC 10-K filings.
$1M in FY2022 with a 3-year CAGR of -26.9%.
Declined from $3M to $1M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -26.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ENDONOVO THERAPEUTICS, INC.'s total assets has declined for 4 consecutive years.
- 3-year CAGR of -26.9%, indicating a declining trend.
- In FY2022, total assets decreased 36.2% year-over-year.
- Peak total assets was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $1.3M | -36.2% |
| FY2021 | $2.0M | -23.0% |
| FY2020 | $2.6M | -20.4% |
| FY2019 | $3.3M | -22.8% |
| FY2018 | $4.2M | +1231.2% |
| FY2016 | $318.7K | -22.2% |
| FY2015 | $409.4K | +797.9% |
| FY2014 | $45.6K | -37.8% |
| FY2011 | $73.3K | - |
As of FY2022 · SEC 10-K · Updated Jun 29, 2026